Bed Bath & Beyond Inc. (BBBY) Shares Sold by Deutsche Bank AG

Deutsche Bank AG lessened its holdings in shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY) by 47.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 878,955 shares of the retailer’s stock after selling 783,156 shares during the period. Deutsche Bank AG owned approximately 0.62% of Bed Bath & Beyond worth $19,324,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Janney Montgomery Scott LLC raised its holdings in Bed Bath & Beyond by 27.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 16,537 shares of the retailer’s stock valued at $388,000 after acquiring an additional 3,552 shares in the last quarter. Twin Capital Management Inc. raised its holdings in Bed Bath & Beyond by 6.4% in the 3rd quarter. Twin Capital Management Inc. now owns 59,498 shares of the retailer’s stock valued at $1,396,000 after acquiring an additional 3,562 shares in the last quarter. Ffcm LLC raised its holdings in Bed Bath & Beyond by 2,958.6% in the 3rd quarter. Ffcm LLC now owns 4,435 shares of the retailer’s stock valued at $104,000 after acquiring an additional 4,290 shares in the last quarter. Tredje AP fonden raised its holdings in Bed Bath & Beyond by 13.9% in the 3rd quarter. Tredje AP fonden now owns 41,354 shares of the retailer’s stock valued at $977,000 after acquiring an additional 5,050 shares in the last quarter. Finally, Rhumbline Advisers raised its holdings in Bed Bath & Beyond by 2.2% in the 3rd quarter. Rhumbline Advisers now owns 251,396 shares of the retailer’s stock valued at $5,900,000 after acquiring an additional 5,310 shares in the last quarter. 91.31% of the stock is owned by institutional investors and hedge funds.

How to Become a New Pot Stock Millionaire

Several equities analysts have commented on BBBY shares. ValuEngine raised Bed Bath & Beyond from a “hold” rating to a “buy” rating in a report on Friday, December 1st. Zacks Investment Research upgraded Bed Bath & Beyond from a “hold” rating to a “buy” rating and set a $26.00 price objective on the stock in a research note on Tuesday, February 20th. TheStreet lowered Bed Bath & Beyond from a “c” rating to a “d+” rating in a research note on Wednesday, December 20th. Barclays lowered their price objective on Bed Bath & Beyond from $30.00 to $25.00 and set an “equal weight” rating on the stock in a research note on Thursday, December 21st. Finally, Wedbush set a $23.00 price objective on Bed Bath & Beyond and gave the company a “hold” rating in a research note on Wednesday, December 27th. Nine research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the company’s stock. Bed Bath & Beyond presently has a consensus rating of “Hold” and an average price target of $25.35.

In related news, VP Matthew Fiorilli sold 16,957 shares of the stock in a transaction that occurred on Thursday, December 28th. The stock was sold at an average price of $22.62, for a total transaction of $383,567.34. Following the sale, the vice president now directly owns 97,419 shares in the company, valued at approximately $2,203,617.78. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 5.00% of the stock is owned by corporate insiders.

Shares of Bed Bath & Beyond stock opened at $21.30 on Friday. The company has a market capitalization of $3,033.40, a P/E ratio of 5.90, a P/E/G ratio of -3.85 and a beta of 1.10. Bed Bath & Beyond Inc. has a 12-month low of $19.07 and a 12-month high of $40.76. The company has a current ratio of 1.67, a quick ratio of 0.31 and a debt-to-equity ratio of 0.54.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3298546/bed-bath-beyond-inc-bbby-shares-sold-by-deutsche-bank-ag.html.

About Bed Bath & Beyond

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

Want to see what other hedge funds are holding BBBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bed Bath & Beyond Inc. (NASDAQ:BBBY).

Institutional Ownership by Quarter for Bed Bath & Beyond (NASDAQ:BBBY)

Receive News & Ratings for Bed Bath & Beyond Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Viberate  Trading Up 16.8% Over Last Week
Viberate Trading Up 16.8% Over Last Week
GoldCoin Trading Up 61.8% This Week
GoldCoin Trading Up 61.8% This Week
Monkey Project 24-Hour Trading Volume Hits $36,275.00
Monkey Project 24-Hour Trading Volume Hits $36,275.00
Zacks: Analysts Set $13.50 Price Target for Manitex International Inc.
Zacks: Analysts Set $13.50 Price Target for Manitex International Inc.
Zacks: Carriage Services, Inc.  Given $32.00 Consensus Target Price by Brokerages
Zacks: Carriage Services, Inc. Given $32.00 Consensus Target Price by Brokerages
Apricus Biosciences  Hits New 12-Month High and Low at $0.25
Apricus Biosciences Hits New 12-Month High and Low at $0.25


© 2006-2018 Ticker Report. Google+.